MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics
— Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection…
AI and Sustainability: Akkodis showcases the future of sustainable and digital innovation at the Paris Air Show 2025
The Smart Industry leader supports major companies in the aviation, aerospace and…
Miles Education and St. James School of Medicine partner to enable Indian NEET Qualifiers to become Licensed U.S. Doctors
BANGALORE, India, June 4, 2025 /PRNewswire/ --Â Miles Education, a global ed-tech leader…
TOPPAN Security Strengthens Market Leadership in Asia with Acquisition of dzcard Group
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- TOPPAN Security, a global leader…
World’s Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care
New global education initiative unveiled at 2025 PTCOG Annual Conference Louvain-la-Neuve, Belgium,…
MindHYVE.ai Establishes Strategic Agenda to Launch Africa Headquarters in Nairobi by Q4 2025 as Part of Global Mission to Democratize Access to Essential Services through Agentic AI
NAIROBI, Kenya, June 3, 2025 /PRNewswire/ -- MindHYVE.aiâ„¢, a global leader in…
Deckers Brands to Present at Upcoming Conferences
GOLETA, Calif.--(BUSINESS WIRE)--Deckers Brands (NYSE:DECK), a global leader in designing, marketing and…
Altair to Showcase AI-Powered Engineering, Smart Manufacturing, and Connected Aerospace Solutions at Paris Air Show 2025
Live demonstrations will highlight how computational intelligence is shaping the future of…
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](https://i0.wp.com/ml-eu.globenewswire.com/media/NjEzMmQ4NzAtZTBkMS00ZDhhLTkyYjgtOGM3YzY1ZWM5M2U5LTEwMTQyODItMjAyNS0wNi0wMi1lbg==/tiny/Sandoz-International-GmbH.png?w=420&resize=420,280&ssl=1 "Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]")
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA…
MinIO AIStor Sets New Standard for AI and Data-Intensive Workloads with Industry-First AWS S3 Express API Support
Enterprise object storage with built-in replication brings S3 Express API performance to…